Mikhail Blagosklonny – The Accomplished Scientist
Mr. Mikhail Blagosklonny is a renowned professor and scientist in the field of Oncology at the Roswell Park Cancer Institute in New York, United States. First, Professor Blogosklonny achieved his M.D in Internal Medicine, together with his PhD in Experimental Medicine and Cardiology, from St Petersburg’s Pavlov State Medical University.
In year 2002, Professor Blagosklonny got the green light from the New York Medical College where he was subsequently appointed as Associate Professor of Medicine. Proceeding from there, Mikhail Blagosklonny went on to Ordway Research Institute and was appointed as the Senior Scientist. By this time, the incredible expertise and flawless success life story of this Oncologist was approaching the zenith.
But fortune has more open doors for the king of Oncology.
The Journey to Roswell Cancer Institute
On April 15th, 2009, Professor Mikhail Blagosklonny was, yet again, appointed member and professor of Oncology at Rosswell Park Cancer Institute, Buffalo, NY. The numerous and invaluable skills and experience he had gained on the road, were brought to bear at Rosswell where he became a worldwide distinguished professor. It was from here that Mikhail Blagosklonny came into limelight.
Read more on Impact Journals.
The Hypothesis and Works Of Mikhail Blagosklonny
The major hypothesis formulated and the research undertaken by Professor Blagosklonny, were primarily centred around cancer and targeted cancer therapies that seek to protect normal human cells from damages, including the underlying mechanisms of aging and anti-aging drugs.
For example, it was Mikhail Blagosklonny who formulated a very popular hypothesis which deals on the possibility of employing TOR Signalling in combating aging and cancer, as well as the proposed use of Rapamycin, a well known cancer drug, as a possible treatment to enhance the life span of affected victims.
Today, Mikhail Blagosklonny is an author of over 170 researched articles and journals, reviews and book chapters. He also stands out as the Editor-in-chief of Cell Cycle, as well as the Associate Editor of Cancer Research, Cancer biology and Therapy, Authophagy, Cell death and Differentiation, etc.
Without controversy, one can rightly conclude that Professor Mikhail Blagosklonny is a rare gem: the Marradona of modern day Oncology!
Visit ResearchGate.Net to know more about Mikhail’s latest work.